Whole brain radiation therapy (WBRT) is the standard treatment for patients with brain metastases, and is often used in conjunction with stereotactic radiotherapy for patients with a limited number of brain metastases, as well as prophylactic cranial irradiation. The use of open fields (conventionally used for WBRT) leads to higher doses to the brain periphery if dose is prescribed to the brain center at the largest lateral radius. These dose variations potentially compromise treatment efficacy and translate to increased side effects. The goal of this research was to design and construct a 3D 'brain wedge' to compensate dose heterogeneities in WBRT. Radiation transport theory was invoked to calculate the desired shape of a wedge to achieve a uniform dose distribution at the sagittal plane for an ellipsoid irradiated medium. The calculations yielded a smooth 3D wedge design to account for the missing tissue at the peripheral areas of the brain. A wedge was machined based on the calculation results. Three ellipsoid phantoms, spanning the mean and ± two standard deviations from the mean cranial dimensions were constructed, representing 95% of the adult population. Film was placed at the sagittal plane for each of the three phantoms and irradiated with 6 MV photons, with the wedge in place. Sagittal plane isodose plots for the three phantoms demonstrated the feasibility of this wedge to create a homogeneous distribution with similar results observed for the three phantom sizes, indicating that a single wedge may be sufficient to cover 95% of the adult population. The sagittal dose is a reasonable estimate of the off-axis dose for whole brain radiation therapy. Comparing the dose with and without the wedge the average minimum dose was higher (90% versus 86%), the maximum dose was lower (107% versus 113%) and the dose variation was lower (one standard deviation 2.7% versus 4.6%). In summary, a simple and 
effective 3D wedge for whole brain radiotherapy has been developed. The wedge gives a more uniform dose distribution than commonly used techniques. Further development and shape optimization may be necessary prior to clinical implementation.
(Some figures in this article are in colour only in the electronic version)
Introduction
Whole brain radiotherapy is the standard treatment for patients with brain metastases. It is commonly combined with surgery or radiosurgery in patients with up to four brain metastases to improve local and distant brain control Khuntia 2005, Aoyama et al 2006) . Whole brain irradiation is also indicated for prophylactic treatment in patients with limited and extensive stage small-cell carcinoma to reduce the high incidence of brain failures and increase overall survival rates in patients with small-cell carcinoma (Auperin et al 1999 , Slotman et al 2007 . Prophylactic cranial irradiation (PCI) in non-small-cell lung cancer patients is presently under investigation.
The true toxicity that is induced by WBRT in adults is not very clear. Patients who undergo WBRT may experience several types of associated side effects (Gerrard et al 2003 , Kondziolka et al 2005 . These include hair loss, erythema, speech problems, hearing difficulty, headaches, nausea and vomiting, changes in appetite, fatigue and decreased libido. Concomitant anticonvulsive or symptomatic medication and/or systemic antineoplastic therapy add to the observed toxicities (Nieder et al 1999 , Hempen et al 2002 , Penitzka et al 2002 . With the standard treatment technique using lateral opposing treatment fields, intracranial dose increases of on average >10% have been calculated (Yu et al 2007) . These high dose areas are observed not only in intracranial areas with a smaller diameter in the anterior, superior and posterior parts of the brain, but to an even larger extent in the scalp areas that are tangentially hit by the treatment beams. Dose increases at the hair follicles in these areas of >25% of the prescribed dose have been measured (Lawenda et al 2004) . Hair loss is a visible and very stressful side effect of WBRT that occurs in nearly all patients. Lawenda et al (2004) described a dependence of hair follicle dose and permanent hair loss with an estimated D 50 of 43 Gy.
A reduction of dose heterogeneities during WBRT therefore has the potential to reduce the risk of permanent hair loss. Improved dose homogeneity might also reduce other radiationinduced side effects of WBRT of which a dose dependency is still unknown. Reducing the risk of therapy-related sequelae is particularly important for patients with a longer life expectancy such as those undergoing prophylactic brain irradiation.
As two-dimensional wedges are not appropriate to conform to the three-dimensional (3D) cranial shape, open fields are typically used. The use of open fields leads to higher doses to the brain periphery if dose is prescribed to mid-plane for the largest lateral dimension. These dose variations potentially compromise treatment efficacy and translate to increased side effects. Thus, the aim of this research was to design and construct a three-dimensional 'brain wedge' to investigate homogeneity of dose treatment for WBRT.
Method and materials
In order to investigate the dose homogeneity, a wedge had first to be designed and manufactured, cranial phantoms made and the experimental procedure developed. These steps are described below.
Wedge design theory
Simply put, the wedge thickness is determined by computing the required thickness to obtain approximately equal dose in the sagittal plane after passing through both the wedge and the head. The derivation is given in equations (1)-(9). In situations of electronic equilibrium (such as that which exists for whole brain radiotherapy), Attix (1979) showed that dose, D, equals collision kerma, K c :
where (E) is the energy fluence for a spectrum of photons of energy E and µ en (E)/ρ is the mass absorption coefficient at energy E. If we make the assumption that the total kerma is proportional to the primary kerma (used successfully in a two-dimensional wedge-modification project (Keall et al 1997) ) and designating the incident photon spectrum at energy E as 0 (E 
where µ w is the attenuation coefficient of the head and t w (x, y) is the thickness of the path length of the radiation beam to a point (x, y) on the sagittal plane. If the cranial shape is assumed to be a 3D ellipsoid, t w as a function of x and y is given by the distance from a point on the sagittal plane (x, y, z = 0) to the intersection of a line originating from the linear accelerator target (x = 0, y = 0, z = −SAD) and the surface of the ellipsoid:
After passing through the brain wedge of thickness t b (x, y) and the attenuation coefficient µ b , the dose, D b , will be given by
Our ideal dose, D ideal , found with the ideal wedge thickness t ideal (x, y) is
By invoking the mean value theorem for integrals, the above equations reduce to
where µ b and µ b are the attenuation coefficients for the energies E and E in the interval (0, E max ) for equations (6) and (7), respectively. These equations can be solved for a depth t w to obtain
Hence,
Renaming
Using this theory, the prototype dimensions were calculated, and a prototype wedge machined. The computer designed and machined brain wedge are shown in figure 1. 
D p /D W/2 can be shown to be approximately 1. For the farthest off-axis point for the widest phantom (15.5 cm), inserting values at the depth of maximum dose (1.5 cm for a 6 MV beam) for an 18 cm 2 equivalent field size, TMR values 1, 0.868 and 0.710 for depths 1.5, 7.75 and 14 cm, respectively, yields an off-axis dose less than 1.8% higher than that on the central axis.
All other values in the volume (outside of the entrance and exit regions) will be less than 2% different from the corresponding central axis values. Thus, the dose area histograms at the central sagittal plane are a reasonable approximation to the dose perpendicular to this plane. Only the measured sagittal plane results will be considered further in this work.
Cranial phantom design
Cranial phantoms were developed for the experimental verification. Three phantoms, representing the mean cranial size, and ± two standard deviations from the mean cranial size were constructed (see table 1). These values were chosen to represent 95% of the adult population based on the anthropometric measurements of Hall et al (1989) . Epoxy was used in the phantom construction as this has similar radiological properties as brain tissue at megavoltage photon energies. The density of epoxy is nominally 1.07 g cm −3 . The slight increase in density over brain tissue would be partially compensated by the lack of bone in the phantom-if cranial bone density is ∼1.8 and brain density is ∼1.0 g cm −3 , then 7.15 cm of epoxy (half of the mean cranial width from Hall et al (1989) ) equals 0.6 cm of cranial bone and 6.5 cm of brain. The phantoms were cut in the sagittal mid-plane to allow film dosimetry (see figure 2) .
Experimental method
The phantoms were aligned with the radiation beam using the light field. In the anterior, posterior and superior borders the field was expanded by 1-2 cm to generously account for any setup errors (also termed skin flash). The inferior border was set to the center of the phantom ellipsoid. Clinically the lower border is typically set at the maximum diameter of the brain, i.e. approximately at the location of the lateral ventricles, the capsula interna and the nucleus caudatus. Both asymmetric jaw (half beam block on the inferior border) and symmetric jaw fields were studied. The symmetric fields were included as not all linear accelerators used for whole brain radiotherapy have asymmetric jaws, particularly in developing countries.
Kodak XV films were placed at the sagittal plane for each of the three phantoms and irradiated with the wedge in place. Absolute dose was measured using the calibration procedure developed for VCU's IMRT quality assurance procedures (Sakthi et al 2006) . 6 MV energy was used per department protocol. A picture of the experimental setup with the brain wedge in place is shown in figure 2. Note that the collimator with the brain wedge and phantom would be rotated 90
• anticlockwise from the viewer's perspective for a clinical treatment, however it was experimentally easiest to place the flat side of the phantom on the couch. The film results were normalized to 100% as the mean dose within the 'brain' area, and the geometric symmetry of the phantom shape was used to average the dose about the length = 0 axis. If appropriately commissioned within a treatment planning system, the monitor units could be scaled to deliver the desired dose at a point or volume in a patient.
Assessment of dose to the brain
For the dose assessment to the brain, the cranium thickness was assumed to be 8 mm. To account for penumbral effects, the dose within 8 mm of the inferior field edge was not included. 
Results
The measured central axis isodose curves with and without the brain wedge are shown in figure 3 for the small, medium and large phantoms for the symmetric setup. For all three phantom sizes the 100% area is increased with the brain wedge and extends further inferiorly. The superior hotspots and inferior cold spots seen for the open field cases are reduced or eliminated with the brain wedge. The symmetric field measurements were similar to asymmetric values (isodose curves not shown, but the data is summarized in table 2).
Using the values inside the 'brain', 8 mm inside the cranial surface and 8 mm from the inferior field border, the isodose plots in figure 3 can be computed as dose area histograms. These measured dose area histograms with and without the brain wedge for the three phantom sizes are shown in figure 4. The curves are clearly steeper with the brain wedge indicating a more homogeneous dose distribution, with a higher minimum and lower maximum than for the open field cases. Table 2 quantifies the minimum, maximum and spread (one standard deviation) of the measured dose with and without the wedge for the three phantom sizes. In all cases the brain wedge has a higher minimum dose (mean 4%, range 1-7), lower maximum dose (mean 6%, range 4-8) and smaller dose spread (mean 1.9%, range 1.5-2.2).
Discussion
A 3D 'brain wedge' has been developed based on transport theory with the aim of creating a uniform mid-plane sagittal dose distribution for WBRT. A prototype wedge was machined and used for experimental verification. A review of anthropometric studies demonstrates a strong similarity in adult head sizes (Hall et al 1989) , a finding that may support the universal application of a single standard device. The current wedge was designed assuming the superior part of the cranium is an ellipsoid, and therefore modifications may be needed using better estimates of the shape variations of cranial anatomy prior to clinical implementation. A previous approach published by Lerch and Newall (1979) used a stack of tempered aluminum plates to achieve compensation and performed dosimetry studies. They also found that the configuration is applicable to a wide range of head sizes.
Appropriate measurements and commissioning would be required prior to clinical implementation. Measurements in a plane perpendicular to the beam direction at various depths in water should be performed to act as the input data for treatment planning. In a treatment planning system, the brain compensator could be included as an additional accessory, e.g. a wedge, or a compensator. Calculations in known geometries, both to reproduce the measured data and assure that the curved surface is accounted for, would be compared to the measured data. Given that the geometry and material of the wedge are accurately known, the use of the compensator with Monte Carlo transport and dose calculation would be possible. The phantoms used for this study could act as appropriate phantoms for this validation process. If 2D plans were to be used with the brain compensator, then a table of appropriate MU values as a function of dose, field size and cranial width would need to be compiled. A long-term goal is to develop a widely applicable 3D wedge that would initially be used for adult prophylactic cranial irradiation and radiation therapy of brain metastases. This basic advancement would later lead to a scaled version of the wedge designed for use with pediatric cases, where developmental and long-term effects of treatment are of great concern. The dose variations for the smaller phantom are less than those of the mean and larger phantom (see figure 4 and table 2), and thus the impact of the wedge with respect to homogeneity improvement in pediatric cases is likely to be smaller than in adults. Conversely, adults with large cranial sizes will benefit most in terms of dose homogeneity through the use of the wedge.
An alternative approach is to create a class of MLC leaf sequence patterns for WBRT or simply use IMRT. Other groups have had promising results to improve WBRT using IMRT (Yu et al 2007) . The recent interest in using IMRT for WBRT, however, originates primarily in the goal to reduce toxicity by avoidance of either the hippocampal area or locations with neural stem cells (Barani et al 2007 , Ghia et al 2007 . The rationale for using a compensator-based approach instead of an IMRT treatment is that typically WBRT treatments are performed on linacs without MLCs in the US, and furthermore in developing countries there is even less access to linacs with MLCs. Even with state-of-the-art IGRT machine availability, WBRT is often performed using traditional 2D techniques.
Conclusions
Typically lateral open fields are used to irradiate a volume with 3D curvature, the skull, during whole brain radiotherapy. A simple and effective dose homogeneity improvement over open fields is to use an anatomic site-specific wedge with curvature in two dimensions. A wedge was designed, manufactured and experimentally investigated on phantoms spanning the range of adult head sizes. In this study the use of the wedge increased the minimum dose to the brain by 4%, decreased the maximum dose by 6% and reduced the dose spread by over 40%.
